According to filings with the U.S. Securities and Exchange Commission, Gregor Diagnostics is raising $6,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Steven Weinstein played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Gregor Diagnostics
Gregor Diagnostics is a molecular diagnostics company developing a revolutionary new screening test for prostate cancer. As a operator of a molecular diagnostics company intended to develop a revolutionary new screening test for prostate cancer. The companys cancer test is developed using seminal fluid as a sample source, can detect prostate cancer at the earliest stages of the disease and differentiate between indolent and aggressive cancer, helping physicians to reduce over diagnosis and overtreatment of indolent prostate cancer and more effective detection and management of aggressive prostate cancer.

To learn more about Gregor Diagnostics, visit http://www.gregordiagnostics.com/

Contact:
Steven Weinstein, Chief Executive Officer
608-340-1896

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.